References of "Rentier, Bernard"
     in
Bookmark and Share    
Full Text
See detailGIGA ANIMAL CARE : Mice & Zebrafish Animal Facility and Transgenesis
Remy, Benoît ULg; Ectors, Fabien ULg; Winandy, Marie ULg et al

Poster (2014, January 27)

In fundamental research, animal models allow to place molecular and cellular observations back into their physiological context. In applied research, these models still remain a mandatory step to evaluate ... [more ▼]

In fundamental research, animal models allow to place molecular and cellular observations back into their physiological context. In applied research, these models still remain a mandatory step to evaluate the efficiency and the toxicity of potential treatments, before going to clinical trials. Mouse and Zebrafish (Danio rerio) are two very interesting models because of a short live cycle and a high prolificacy. They require a limited space. Their genome is well known and shows a high homology with the human. Many tools are available to produce transgenic mice or zebrafishes. Many tests are validated using both these species. [less ▲]

Detailed reference viewed: 31 (9 ULg)
Full Text
See detailWhere are we today ? The ORBi experience
Rentier, Bernard ULg

Scientific conference (2013, November 19)

Detailed reference viewed: 379 (18 ULg)
Full Text
See detailPerspectives of a Vice-Chancellor
Rentier, Bernard ULg

Scientific conference (2013, November 01)

Detailed reference viewed: 146 (12 ULg)
Full Text
See detailTransgresser les tabous
Rentier, Bernard ULg

Speech (2013)

Detailed reference viewed: 27 (8 ULg)
Full Text
See detailPerspectives on OA Policy: The Institutional Perspective
Rentier, Bernard ULg

Scientific conference (2013, February 06)

Detailed reference viewed: 36 (7 ULg)
Full Text
Peer Reviewed
See detailPrimary Versus Secondary Failure After Varicella Vaccination: Implications for Interval Between 2 Doses
Bonanni, Paolo; Gershon, Anne; Gershon, Michael et al

in Pediatric Infectious Disease Journal (2013), 32(7), 305-313

Background: Two-dose varicella vaccination is recommended for optimal control of varicella in populations with high (>90%) 1-dose coverage. Optimal timing of the second dose may depend on whether ... [more ▼]

Background: Two-dose varicella vaccination is recommended for optimal control of varicella in populations with high (>90%) 1-dose coverage. Optimal timing of the second dose may depend on whether breakthrough varicella results from primary vaccine failure (no protective immunity after vaccination) or secondary vaccine failure (waning protective immunity). Methods: Published literature (1995 to 2012) on vaccine failure after varicella vaccination cited in PubMed and other online sources was reviewed. Results: Nineteen publications detailed 21 varicella outbreaks with breakthrough varicella rates ranging from 0% to 42%; the publications showed no consistent trend between breakthrough varicella rate and time since vaccination. Conclusions: Literature to date indicates a relatively high rate of primary vaccine failure and limited evidence of secondary vaccine failure among 1-dose varicella vaccine recipients, suggesting that a short interval between 2 doses might be preferable in countries considering implementation of universal varicella vaccination to reduce breakthrough varicella. However, any potential disruption to well-established vaccination schedules should be considered. [less ▲]

Detailed reference viewed: 38 (5 ULg)
Full Text
See detailOA à l’Université de Liège : le pari d’ORBi
Rentier, Bernard ULg; Thirion, Paul ULg

Scientific conference (2012, October 23)

Detailed reference viewed: 367 (67 ULg)
Full Text
See detailOA at Liège University : the ORBi gamble
Rentier, Bernard ULg; Thirion, Paul ULg

Scientific conference (2012, October 22)

Detailed reference viewed: 65 (10 ULg)
Full Text
See detailWhat should be done on policy level to give Open Access in Belgium a boost? The CRef answer
Conti, Calogero; Delvaux, Bruno; Lambert, Jean-Paul et al

Diverse speeche and writing (2012)

Detailed reference viewed: 219 (20 ULg)
Full Text
See detailQu’est-ce qu’une université ?
Rentier, Bernard ULg

Speech (2012)

Detailed reference viewed: 24 (5 ULg)
Full Text
See detailThe Liège ORBi model: Mandatory policy without rights retention but linked to assessment processes
Rentier, Bernard ULg; Thirion, Paul ULg

Conference given outside the academic context (2011)

The decision to build an institutional repository at the University of Liège was taken in 2005. It took 3 years to prepare for a faultless start in November 2008. A strong communication campaign conveyed ... [more ▼]

The decision to build an institutional repository at the University of Liège was taken in 2005. It took 3 years to prepare for a faultless start in November 2008. A strong communication campaign conveyed the Open Access concept to the ULg research community. A name was coined to personalise the concept : ORBi (Open Repository and Bibliography, http://orbi.ulg.ac.be/), suggesting an improved worldwide audience. A special effort in internal communication was devoted to acceptance of the mandate. It appeared essential to make it plain that ORBi would offer an unprecedented increase in readership, but that it would only be valuable if all ULg members would abide by the new rules. Any mandate needs some coercitive persuasion. Rather than resting on advocacy, we linked internal assessment to the scientific production stored in ORBi. Those applying for promotion have no choice but to file all their production in full text. This created waves of progression. Since then, evidence for a much increased readership (about twice, http://opcit.eprints.org/) has transformed the early participants in strong advocates of the repository. 68,000 items have been filed, 41,000 (60,2%) with full text (only mandatory for documents published later that 2002). According to ROAR (http://roar.eprints.org ), out of 1,568 IRs, ORBi comes 27th for the number of references, 15th for « high activity level » and 1st for « medium activity level » (number of days with 10-99 deposits/day). ORBi is now considered a success by almost all ULg members. Its advantages to individual authors have become a better incentive than the mandate itself. [less ▲]

Detailed reference viewed: 928 (49 ULg)
Full Text
See detailMieux vaut prévenir que guérir
Rentier, Bernard ULg

Speech (2011)

Detailed reference viewed: 26 (1 ULg)
Full Text
See detailIs Open Access just for articles in STM? Can OA books help Humanities? The Liège Experience
Rentier, Bernard ULg; Thirion, Paul ULg

Scientific conference (2011, February 25)

Detailed reference viewed: 94 (12 ULg)
Full Text
Peer Reviewed
See detailHepatitis C of genotype 2: the role of medical invasive exams.
Putzeys, V.; GERARD, Christiane ULg; Bastens, B. et al

in Acta gastro-enterologica Belgica (2011), 74(2), 277-80

BACKGROUND AND AIM: Hepatitis C virus genotype 2 is the third in order of frequency in Belgium. The aim of this study was to better define the genotype 2 carriers' epidemiology characteristics. METHODS ... [more ▼]

BACKGROUND AND AIM: Hepatitis C virus genotype 2 is the third in order of frequency in Belgium. The aim of this study was to better define the genotype 2 carriers' epidemiology characteristics. METHODS: In a database comprising 1726 viremic hepatitis C virus patient from the south part of Belgium, the files of 98 genotype 2 carriers were reviewed. RESULTS: There was a strong association between genotype 2 and the mode of transmission. The rate of contamination by invasive medical exams was very high (23%), and statistically different from the one of the others genotypes. Eligibility for antiviral therapies and the rate of sustained viral response were high. CONCLUSION: HCV genotype 2 was highly associated with transmission by invasive medical exams. [less ▲]

Detailed reference viewed: 83 (13 ULg)
Full Text
See detailSavoir rebondir
Rentier, Bernard ULg

Speech (2010)

Detailed reference viewed: 20 (1 ULg)
Full Text
See detailChercheurs, vos papiers! Les dépôts institutionnels obligatoires
Rentier, Bernard ULg

in Hermès (2010), (57), 107-108

Detailed reference viewed: 55 (13 ULg)
Full Text
See detailPrimary versus secondary failure following varicella vaccination: implications for interval between two doses-Literature review
Bonanni, Paolo; Gershon, Anne; Gershon, Michael et al

Poster (2010)

Detailed reference viewed: 57 (12 ULg)
Full Text
Peer Reviewed
See detailVaricella vaccination in Europe – taking the practical approach
Bonanni, Paolo; Breuer, Judith; Gershon, Anne A. et al

in BMC Medicine (2009), 7(26), 1-38

Varicella is a common viral disease affecting almost the entire birth cohort. Although usually self-limiting, some cases of varicella can be serious, with 2 to 6% of cases attending a general practice ... [more ▼]

Varicella is a common viral disease affecting almost the entire birth cohort. Although usually self-limiting, some cases of varicella can be serious, with 2 to 6% of cases attending a general practice resulting in complications. The hospitalisation rate for varicella in Europe ranges from 1.3 to 4.5 per 100,000 population/year and up to 10.1% of hospitalised patients report permanent or possible permanent sequelae (for example, scarring or ataxia). However, in many countries the epidemiology of varicella remains largely unknown or incomplete. In countries where routine childhood vaccination against varicella has been implemented, it has had a positive effect on disease prevention and control. Furthermore, mathematical models indicate that this intervention strategy may provide economic benefits for the individual and society. Despite this evidence and recommendations for varicella vaccination by official bodies such as the World Health Organization, and scientific experts in the field, the majority of European countries (with the exception of Germany and Greece) have delayed decisions on implementation of routine childhood varicella vaccination, choosing instead to vaccinate high-risk groups or not to vaccinate at all. In this paper, members of the Working Against Varicella in Europe group consider the practicalities of introducing routine childhood varicella vaccination in Europe, discussing the benefits and challenges of different vaccination options (vaccination vs. no vaccination, routine vaccination of infants vs. vaccination of susceptible adolescents or adults, two doses vs. one dose of varicella vaccine, monovalent varicella vaccines vs. tetravalent measles, mumps, rubella and varicella vaccines, as well as the optimal interval between two doses of measles, mumps, rubella and varicella vaccines). Assessment of the epidemiology of varicella in Europe and evidence for the effectiveness of varicella vaccination provides support for routine childhood programmes in Europe. Although European countries are faced with challenges or uncertainties that may have delayed implementation of a childhood vaccination programme, many of these concerns remain hypothetical and with new opportunities offered by combined measles, mumps, rubella and varicella vaccines, reassessment may be timely. In countries where routine childhood vaccination against varicella has been implemented, it has had a positive effect on disease prevention and control. Furthermore, mathematical models indicate that this intervention strategy may provide economic benefits for the individual and society. Despite this evidence and recommendations for varicella vaccination by official bodies such as the World Health Organization, and scientific experts in the field, the majority of European countries (with the exception of Germany and Greece) have delayed decisions on implementation of routine childhood varicella vaccination, choosing instead to vaccinate high-risk groups or not to vaccinate at all. In this paper, members of the Working Against Varicella in Europe group consider the practicalities of introducing routine childhood varicella vaccination in Europe, discussing the benefits and challenges of different vaccination options (vaccination vs. no vaccination, routine vaccination of infants vs. vaccination of susceptible adolescents or adults, two doses vs. one dose of varicella vaccine, monovalent varicella vaccines vs. tetravalent measles, mumps, rubella and varicella [MMRV] vaccines, as well as the optimal interval between two doses of MMRV vaccines). Assessment of the epidemiology of varicella in Europe and evidence for the effectiveness of varicella vaccination provides support for routine childhood programmes in Europe. Although European countries are faced with challenges or uncertainties that may have delayed implementation of a childhood vaccination programme, many of these concerns remain hypothetical and with new opportunities offered by combined MMRV vaccines, reassessment may be timely. [less ▲]

Detailed reference viewed: 203 (51 ULg)